{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:26:57Z","timestamp":1777973217424,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ekir.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T03:38:48Z","timestamp":1608003528000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL\u2013Negative Myeloproliferative Neoplasms"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-8584","authenticated-orcid":false,"given":"Julie","family":"Belliere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Colombat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Kounde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Recher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Huart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Demas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Luquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Beyne-Rauzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Tavitian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.12.005_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.12.005_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canep.2016.03.011","article-title":"Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004-15","volume":"42","author":"Roman","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ekir.2020.12.005_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.exphem.2015.06.007","article-title":"Pathogenesis of myeloproliferative neoplasms","volume":"43","author":"Skoda","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ekir.2020.12.005_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.critrevonc.2015.03.002","article-title":"Chronic myelomonocytic leukemia: Forefront of the field in 2015","volume":"95","author":"Benton","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ekir.2020.12.005_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14737140.2018.1457441","article-title":"Current approaches to challenging scenarios in myeloproliferative neoplasms","volume":"18","author":"Zimran","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ekir.2020.12.005_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.crad.2017.05.014","article-title":"Imaging features of myeloproliferative neoplasms","volume":"72","author":"Murphy","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ekir.2020.12.005_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-019-03708-9","article-title":"Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis","volume":"98","author":"Strati","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ekir.2020.12.005_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3904\/kjim.2016.263","article-title":"Chronic kidney disease in the BCR-ABLl-negative myeloproliferative neoplasm: A single-center retrospective study","volume":"33","author":"Baek","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib9","first-page":"33","article-title":"Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy","volume":"11","author":"Hyams","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.ekir.2020.12.005_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.revmed.2013.04.014","article-title":"Les glom\u00e9rulopathies associ\u00e9es aux n\u00e9oplasies my\u00e9loprolif\u00e9ratives [Myeloproliferative neoplasms related glomerulopathy]","volume":"35","author":"Bardy","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ekir.2020.12.005_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000168720","article-title":"Nephrotic syndrome associated with agnogenic myeloid metaplasia","volume":"14","author":"Perazella","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2020.12.005_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.005_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008893","article-title":"Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients","volume":"5","author":"Ugo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.12.005_bib14","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.005_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2011.32","article-title":"Section 2: AKI Definition","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2020.12.005_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ekir.2016.09.002","article-title":"Lysozyme-induced nephropathy","volume":"2","author":"Santoriello","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.12.005_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nrneph.2015.15","article-title":"Renal effects of targeted anticancer therapies","volume":"11","author":"Porta","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2020.12.005_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.005_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ajh.24984","article-title":"Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance","volume":"93","author":"Ribes","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ekir.2020.12.005_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.ajkd.2008.11.013","article-title":"A\u00a0forgotten cause of kidney injury in chronic myelomonocytic leukemia","volume":"54","author":"Patel","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.12.005_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/nep.13056","article-title":"Lysozyme nephropathy in haematologically stable chronic myelomonocytic leukaemia","volume":"23","author":"Goh","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.ekir.2020.12.005_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2009.07785.x","article-title":"Renal infiltration associated with chronic myelomonocytic leukaemia: images in haematology","volume":"147","author":"Kobayashi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2020.12.005_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib25","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3995","article-title":"Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition","volume":"21","author":"Jeremy Wen","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2020.12.005_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2018-11-876888","article-title":"Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis","volume":"133","author":"Fenaux","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.12.005_bib29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1172\/JCI124793","article-title":"UPAR isoform 2 forms a dimer and induces severe kidney disease in mice","volume":"129","author":"Wei","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2020.12.005_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.ajkd.2019.05.016","article-title":"Novel detection of CALR-mutated cells in myeloproliferative neoplasm-related glomerulopathy with interstitial extramedullary hematopoiesis: a case report","volume":"74","author":"Maruyama","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.12.005_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study","volume":"55","author":"Mekinian","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.ekir.2020.12.005_bib32","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1080\/10428194.2019.1599114","article-title":"Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"60","author":"Fraison","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ekir.2020.12.005_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0121-6","article-title":"Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib","volume":"16","author":"Rajasekaran","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2020.12.005_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V57.1.182.182","article-title":"5-Azacytidine and renal tubular dysfunction","volume":"57","author":"Peterson","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.12.005_bib35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.kint.2017.03.038","article-title":"DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8","volume":"92","author":"Guo","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.12.005_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6327","key":"10.1016\/j.ekir.2020.12.005_bib37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.12.005_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223803","article-title":"Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis","volume":"2018","author":"Bohra","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ekir.2020.12.005_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2017.06.022","article-title":"Membranous nephropathy and intrarenal extramedullary hematopoiesis in a patient with myelofibrosis","volume":"70","author":"Philipponnet","year":"2017","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920318027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920318027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:35:34Z","timestamp":1762832134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024920318027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2468024920318027"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.005","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL\u2013Negative Myeloproliferative Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}